1. Segal Cancer Center, Lady Davis Institute, Jewish General Hospital, Montreal, QC, Canada;
2. Department of Molecular Biology and Biochemistry, Simon Fraser University, Burnaby, BC, Canada;
3. Centre for Lymphoid Cancer, Department of Experimental Therapeutics, University of British Columbia, Vancouver, BC, Canada;
4. Hematology, QEII Health Sciences Centre, Halifax, NS, Canada;
5. Departement d'oncologie et hematologie, Hopital Sacre-Coeur, Montreal, QC, Canada;
6. Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada;
7. Department of Oncology and Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, QC, Canada;
8. Department of Pathology, Jewish General Hospital, Montreal, QC, Canada;
9. Lady Davis Institute, Department of Oncology and Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, QC, Canada;
10. Department of Radiology, Jewish General Hospital, Montreal, QC, Canada;
11. Ozmosis Research, Toronto, ON, Canada;
12. Quebec Clinical Research Organization in Cancer, Montreal, QC, Canada; and
13. Genome Sciences Centre, BC Cancer Agency, Vancouver, BC, Canada